Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Nuclear Medicine

Free Subscription Articles published in Semin Nucl Med Retrieve available abstracts of 131 articles: HTML format

Single Articles

February 2026
1. PANDYA K, Lazar A, Serrano LL, Amon MC, et al
   Can FAPI-PET imaging address unmet needs in nephro-urology?
   Semin Nucl Med. 2026 Feb 6:S0001-2998(26)00001.
   PubMed     Abstract available
   
   
   January 2026
2. FUSO GA, Bianciardi G, Mei R, Brusa I, et al
   Retraction notice to Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine [Seminars Nucl Med 55 (2025) 648-663].
   Semin Nucl Med. 2026 Jan 16:S0001-2998(25)00185.
   PubMed    
   
   
   
3. VORSTER M, Sathekge M
   (18)F-FDG PET/CT for prediction of response in breast cancer.
   Semin Nucl Med. 2026 Jan 8:S0001-2998(25)00173.
   PubMed     Abstract available
   
   
   
4. SEN I, Malik D, Thakral P
   Clinical implementation of RECIP 1.0.
   Semin Nucl Med. 2026;56:5-8.
   PubMed     Abstract available
   
   
   
5. WIEFELS C, Juarez-Orozco LE, Craviolatti PS, Diahiliev O, et al
   Artificial intelligence in nuclear cardiology: Technical perspectives, strategic directions, and recommendations from an IAEA expert working group.
   Semin Nucl Med. 2026;56:119-131.
   PubMed     Abstract available
   
   
   
6. AGGARWAL P, Satapathy S, Chandekar KR, Sood A, et al
   Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN).
   Semin Nucl Med. 2026;56:22-30.
   PubMed     Abstract available
   
   
   December 2025
7. CIVAN C, Karpinski MJ, Rahbar K, Fendler WP, et al
   The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects.
   Semin Nucl Med. 2025 Dec 25:S0001-2998(25)00181.
   PubMed     Abstract available
   
   
   
8. SHAGERA QA, Ozturk AA, Pabst KM, Longton E, et al
   FAPI PET imaging value in radiotherapy planning and assessment in head and neck cancers.
   Semin Nucl Med. 2025 Dec 17:S0001-2998(25)00174.
   PubMed     Abstract available
   
   
   
9. ARTESANI A, Olivieri M, Guglielmo P, Marenco M, et al
   PET-CT radiomics for immunotherapy response.
   Semin Nucl Med. 2025 Dec 13:S0001-2998(25)00176.
   PubMed     Abstract available
   
   
   
10. BENTESTUEN M, Dahlsgaard-Wallenius S, Stolberg MMK, Zacho HD, et al
    Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature.
    Semin Nucl Med. 2025 Dec 8:S0001-2998(25)00168.
    PubMed     Abstract available
    
    
    
11. SAFARIAN A, Muin D, Unterrainer L, Hormann A, et al
    The role of non-FDG agents in PET imaging of bladder cancer.
    Semin Nucl Med. 2025 Dec 8:S0001-2998(25)00165.
    PubMed     Abstract available
    
    
    
12. RIZZO A, Treglia G
    PSMA PET in renal cell carcinoma: an update and future aspects.
    Semin Nucl Med. 2025 Dec 3:S0001-2998(25)00166.
    PubMed     Abstract available
    
    
    
13. FILIPPI L, Mass ACL, Arslan E, Alcin G, et al
    Is There a Role of FAPI Pet in Renal and Bladder Cancer?
    Semin Nucl Med. 2025 Dec 1:S0001-2998(25)00157.
    PubMed     Abstract available
    
    
    
14. KATAYEU Y, Grunwald V, Pabst KM, Yesilyurt UU, et al
    New targets of PET imaging for renal cancer.
    Semin Nucl Med. 2025 Dec 1:S0001-2998(25)00159.
    PubMed     Abstract available
    
    
    November 2025
15. YANG R, Lu X, Tang W, Nardo L, et al
    Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma.
    Semin Nucl Med. 2025 Nov 29:S0001-2998(25)00162.
    PubMed     Abstract available
    
    
    
16. UENO Y, Nogami M, Hirota K, Hyodo T, et al
    Any Role of FDG PET in Renal Cancer?
    Semin Nucl Med. 2025 Nov 29:S0001-2998(25)00158.
    PubMed     Abstract available
    
    
    
17. BADRANE I, Nieri A, Albano D, Arslan E, et al
    The Value of FDG PET/CT in Penile Cancer: An Update.
    Semin Nucl Med. 2025 Nov 29:S0001-2998(25)00160.
    PubMed     Abstract available
    
    
    
18. XIE Y, Deng Y, Cruz EB, Pradhan PK, et al
    Clinical Utility of FAPI PET/CT in Diagnosis, Staging, and Response Assessment of Colorectal Cancer.
    Semin Nucl Med. 2025 Nov 28:S0001-2998(25)00163.
    PubMed     Abstract available
    
    
    October 2025
19. HIGUCHI T, Chen X, Siegmund SC, Klimek K, et al
    Recent Advances and Future Trends of[(18)F]-Labeled PET Agents for Renal Imaging.
    Semin Nucl Med. 2025 Oct 15:S0001-2998(25)00124.
    PubMed     Abstract available
    
    
    September 2025
20. KABUNDA J, Ndlovu H, Singh K, Sibiya S, et al
    Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic Frontier.
    Semin Nucl Med. 2025 Sep 26:S0001-2998(25)00118.
    PubMed     Abstract available
    
    
    
21. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    Corrigendum to '18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment' [Seminar in Nuclear Medicine volume 55 (2025):526 -537/Article number YSNUC_51208].
    Semin Nucl Med. 2025 Sep 25:S0001-2998(25)00116.
    PubMed    
    
    
    July 2025
22. NYAKALE N, Maes A, Sathekge M, Li S, et al
    PSMA-Targeted Positron Emission Tomography Imaging in Solid Tumors Other Than Prostate Carcinoma: An Update.
    Semin Nucl Med. 2025 Jul 19:S0001-2998(25)00070.
    PubMed     Abstract available
    
    
    
23. SAFARIAN A, Mirshahvalad SA, Farbod A, Jung T, et al
    Artificial Intelligence for Tumor [(18)F]FDG PET Imaging: Advancements and Future Trends - Part II.
    Semin Nucl Med. 2025 Jul 18:S0001-2998(25)00086.
    PubMed     Abstract available
    
    
    
24. NOVRUZOV E, Mamlins E, Mori Y, Cardinale J, et al
    The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.
    Semin Nucl Med. 2025 Jul 18:S0001-2998(25)00090.
    PubMed     Abstract available
    
    
    
25. FUSO GA, Bianciardi G, Mei R, Brusa I, et al
    Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine.
    Semin Nucl Med. 2025 Jul 16:S0001-2998(25)00069.
    PubMed     Abstract available
    
    
    
26. PABST KM, Fendler WP, Jochheim LS, Herrmann K, et al
    The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update.
    Semin Nucl Med. 2025 Jul 16:S0001-2998(25)00075.
    PubMed     Abstract available
    
    
    
27. LIN W, Huang C, Tan Z, Xu H, et al
    Cu(II)-bis(thioureido) Complex: A Potential Radiotracer for Detecting Oxidative Stress and Neuroinflammation in Neurodegenerative Diseases.
    Semin Nucl Med. 2025;55:577-586.
    PubMed     Abstract available
    
    
    
28. FILIPPI L, Schillaci O
    Global experience in brain amyloid imaging.
    Semin Nucl Med. 2025;55:538-547.
    PubMed     Abstract available
    
    
    June 2025
29. FERRANDO R, Hernandes D, Ghini BG, Coutinho AM, et al
    PET Imaging in Psychiatric Disorders.
    Semin Nucl Med. 2025 Jun 20:S0001-2998(25)00068.
    PubMed     Abstract available
    
    
    
30. RYU J, Oh M
    Positron Emission Tomography in Autism Spectrum Disorder: Current Status and Future Perspectives.
    Semin Nucl Med. 2025 Jun 12:S0001-2998(25)00065.
    PubMed     Abstract available
    
    
    
31. STORMEZAND GN, Doorduin J, Glaudemans AWJM, van der Hoorn A, et al
    Current Developments on [(18)F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System.
    Semin Nucl Med. 2025 Jun 11:S0001-2998(25)00066.
    PubMed     Abstract available
    
    
    
32. YANG YJ, Zhao YX, Li XY, Zuo C, et al
    New Targets for Positron Emission Tomography Imaging in Parkinson s Disease.
    Semin Nucl Med. 2025 Jun 6:S0001-2998(25)00061.
    PubMed     Abstract available
    
    
    
33. DELGADO BOLTON RC, Calapaqui Teran AK, Santiago Almeida L, Paez D, et al
    Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective.
    Semin Nucl Med. 2025 Jun 1:S0001-2998(25)00060.
    PubMed     Abstract available
    
    
    May 2025
34. MENA E, Lindenberg L, Herscovitch P, Sadowski SM, et al
    Advances in Endocrine Tumor PET Imaging Targeting CXCR4 and GLP-1.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00058.
    PubMed     Abstract available
    
    
    
35. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    (18)F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00057.
    PubMed     Abstract available
    
    
    
36. BENDER D
    New Radiopharmaceutical Tools in Imaging.
    Semin Nucl Med. 2025 May 26:S0001-2998(25)00059.
    PubMed     Abstract available
    
    
    
37. BARANSKA K, Niemas K, Pelka K, Kunikowska J, et al
    PET/CT in the Imaging of CNS Tumors.
    Semin Nucl Med. 2025 May 21:S0001-2998(25)00040.
    PubMed     Abstract available
    
    
    
38. LIN Z, Rasinski P, Nilsson T, Holstensson M, et al
    FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview.
    Semin Nucl Med. 2025 May 20:S0001-2998(25)00056.
    PubMed     Abstract available
    
    
    
39. BRINK A, Paez D, Estrada Lobato E, Delgado Bolton RC, et al
    New Targets for Imaging in Nuclear Medicine.
    Semin Nucl Med. 2025 May 6:S0001-2998(25)00039.
    PubMed     Abstract available
    
    
    
40. NERATTINI M, Abenavoli EM, Berti V
    PET/CT in Movement Disorders: Update.
    Semin Nucl Med. 2025 May 3:S0001-2998(25)00036.
    PubMed     Abstract available
    
    
    
41. CAIRNS J, Frood R, Patel C, Scarsbrook A, et al
    The Role of AI in Lymphoma: An Update.
    Semin Nucl Med. 2025;55:377-386.
    PubMed     Abstract available
    
    
    
42. EJAZ A, Naqvi AH, Perumalla HS, Bateman TM, et al
    Assessment of Myocardial Perfusion in Patients After CABG: An Update and Clinical Implications.
    Semin Nucl Med. 2025;55:460-469.
    PubMed     Abstract available
    
    
    April 2025
43. SPOHN SKB, Grosu AL
    Impact of PSMA PET on Radiation Oncology Planning.
    Semin Nucl Med. 2025 Apr 22:S0001-2998(25)00034.
    PubMed     Abstract available
    
    
    
44. VANDERLINDEN G, Vandenberghe R, Vandenbulcke M, Van Laere K, et al
    The Current Role of Tau PET Imaging in Neurodegeneration.
    Semin Nucl Med. 2025 Apr 21:S0001-2998(25)00031.
    PubMed     Abstract available
    
    
    
45. YANG F, Lei B, Zhou Z, Song TA, et al
    AI in SPECT Imaging: Opportunities and Challenges.
    Semin Nucl Med. 2025 Apr 3:S0001-2998(25)00033.
    PubMed     Abstract available
    
    
    March 2025
46. SAFARIAN A, Mirshahvalad SA, Farbod A, Nasrollahi H, et al
    Artificial intelligence for tumor [(18)F]FDG-PET imaging: Advancement and future trends-part I.
    Semin Nucl Med. 2025 Mar 29:S0001-2998(25)00032.
    PubMed     Abstract available
    
    
    
47. KIRIENKO M, Cavinato L, Sollini M
    Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence.
    Semin Nucl Med. 2025 Mar 21:S0001-2998(25)00021.
    PubMed     Abstract available
    
    
    
48. RICHLITZKI C, Manapov F, Holzgreve A, Rabe M, et al
    Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy.
    Semin Nucl Med. 2025 Mar 9:S0001-2998(25)00022.
    PubMed     Abstract available
    
    
    
49. CANGUT B, Akinlusi R, Mohseny A, Ghesani N, et al
    Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals.
    Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00013.
    PubMed     Abstract available
    
    
    
50. MIKKELSEN AFS, Thygesen J, Fledelius J
    Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine.
    Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00015.
    PubMed     Abstract available
    
    
    
51. SAFARIAN A, Mirshahvalad SA, Nasrollahi H, Jung T, et al
    Impact of [(18)F]FDG PET/CT Radiomics and Artificial Intelligence in Clinical Decision Making in Lung Cancer: Its Current Role.
    Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00014.
    PubMed     Abstract available
    
    
    
52. ALORFI F, Bomanji J, Bertoletti L, Fraioli F, et al
    PET/MRI in Non-Small Cell Lung Cancer (NSCLC).
    Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00019.
    PubMed     Abstract available
    
    
    
53. DELEU AL, Shagera QA, Veldhuijzen van Zanten S, Flamen P, et al
    FAPI PET in the Management of Lung Tumors.
    Semin Nucl Med. 2025 Mar 3:S0001-2998(25)00018.
    PubMed     Abstract available
    
    
    February 2025
54. SATHEKGE C, Maes J, Maes A, Van de Wiele C, et al
    FDG PET/CT for Staging Lung Carcinoma: An Update.
    Semin Nucl Med. 2025 Feb 28:S0001-2998(25)00003.
    PubMed     Abstract available
    
    
    
55. AYENI A, Evbuomwan O, Vangu MW
    The Role of [(18)F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer.
    Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00010.
    PubMed     Abstract available
    
    
    
56. BADARNA M, Keidar Z, Arnon-Sheleg E
    Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma.
    Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00009.
    PubMed     Abstract available
    
    
    
57. VINJAMURI S, Pant V
    Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends.
    Semin Nucl Med. 2025 Feb 26:S0001-2998(25)00011.
    PubMed     Abstract available
    
    
    
58. CURRIE GM, Rohren EM
    Potential of Technetium and Rhenium Theranostics.
    Semin Nucl Med. 2025 Feb 24:S0001-2998(25)00006.
    PubMed     Abstract available
    
    
    
59. LOPES L, Lopez-Montes A, Chen Y, Koller P, et al
    The Evolution of Artificial Intelligence in Nuclear Medicine.
    Semin Nucl Med. 2025 Feb 10:S0001-2998(25)00005.
    PubMed     Abstract available
    
    
    January 2025
60. LIU J, Sandhu K, Woon DTS, Perera M, et al
    The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update.
    Semin Nucl Med. 2025 Jan 31:S0001-2998(24)00120.
    PubMed     Abstract available
    
    
    
61. MOHSENINIA N, Eisazadeh R, Mirshahvalad SA, Zamani-Siahkali N, et al
    Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review.
    Semin Nucl Med. 2025 Jan 23:S0001-2998(25)00001.
    PubMed     Abstract available
    
    
    December 2024
62. SACHPEKIDIS C, Goldschmidt H, Edenbrandt L, Dimitrakopoulou-Strauss A, et al
    Radiomics and Artificial Intelligence Landscape for [(18)F]FDG PET/CT in Multiple Myeloma.
    Semin Nucl Med. 2024 Dec 13:S0001-2998(24)00111.
    PubMed     Abstract available
    
    
    November 2024
63. RATHOD N, Jutidamrongphan W, Bosbach WA, Chen Y, et al
    Total Body PET/CT: Clinical Value and Future Aspects of Quantification in Static and Dynamic Imaging.
    Semin Nucl Med. 2024 Nov 29:S0001-2998(24)00110.
    PubMed     Abstract available
    
    
    
64. ZOGHI S, Mingels C, Badawi RD, Spencer BA, et al
    Role of Total Body PET/CT in Inflammatory Disorders.
    Semin Nucl Med. 2024 Nov 21:S0001-2998(24)00107.
    PubMed     Abstract available
    
    
    
65. HAWK KE, Currie GM
    Artificial Intelligence and Workforce Diversity in Nuclear Medicine.
    Semin Nucl Med. 2024 Nov 19:S0001-2998(24)00090.
    PubMed     Abstract available
    
    
    
66. GERKE O, Naghavi-Behzad M, Nygaard ST, Sigaroudi VR, et al
    Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[(18)F]FDG-PET/CT, (18)F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone Scintigraphy.
    Semin Nucl Med. 2024 Nov 14:S0001-2998(24)00093.
    PubMed     Abstract available
    
    
    
67. DIAS AH, Andersen KF, Fosbol MO, Gormsen LC, et al
    Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging.
    Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00092.
    PubMed     Abstract available
    
    
    
68. GODINEZ F, Mingels C, Bayerlein R, Mehadji B, et al
    Total Body PET/CT: Future Aspects.
    Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00096.
    PubMed     Abstract available
    
    
    
69. MARTINEZ-LUCIO TS, Mendoza-Ibanez OI, Liu W, Mostafapour S, et al
    Long Axial Field of View PET/CT: Technical Aspects in Cardiovascular Diseases.
    Semin Nucl Med. 2024 Nov 12:S0001-2998(24)00094.
    PubMed     Abstract available
    
    
    
70. YANG N, Guo XY, Ding J, Wang F, et al
    Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational.
    Semin Nucl Med. 2024 Nov 8:S0001-2998(24)00086.
    PubMed     Abstract available
    
    
    
71. NANNI C, Farolfi A, Castellucci P, Fanti S, et al
    Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology.
    Semin Nucl Med. 2024 Nov 7:S0001-2998(24)00091.
    PubMed     Abstract available
    
    
    
72. DEV ID, Puranik AD, Singh B, Prasad V, et al
    Current and Future Perspectives of PDL1 PET and SPECT Imaging.
    Semin Nucl Med. 2024 Nov 6:S0001-2998(24)00084.
    PubMed     Abstract available
    
    
    
73. LIN Y, Gao H, Zheng J, Al-Ibraheem A, et al
    Clinical Explorations of [(68)Ga] Ga-FAPI-04 and [(18)F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging.
    Semin Nucl Med. 2024 Nov 2:S0001-2998(24)00085.
    PubMed     Abstract available
    
    
    
74. MENA E, Lindenberg L, Choyke PL
    Update on PSMA-based Prostate Cancer Imaging.
    Semin Nucl Med. 2024;54:941-950.
    PubMed     Abstract available
    
    
    
75. O'BRIEN SR, Edmonds CE, Ward RE, Taunk NK, et al
    Update on (18)F-Fluoroestradiol.
    Semin Nucl Med. 2024;54:812-826.
    PubMed     Abstract available
    
    
    October 2024
76. CUMBERS GA, Harvey-Latham ED, Kassiou M, Werry EL, et al
    Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis.
    Semin Nucl Med. 2024 Oct 29:S0001-2998(24)00082.
    PubMed     Abstract available
    
    
    
77. DUVENHAGE J, Kahts M, Summers B, Zeevaart JR, et al
    Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies.
    Semin Nucl Med. 2024 Oct 26:S0001-2998(24)00088.
    PubMed     Abstract available
    
    
    
78. NOGUEIRA-LIMA E, Alves T, Etchebehere E
    (18)F-Fluoride PET/CT-Updates.
    Semin Nucl Med. 2024 Oct 10:S0001-2998(24)00083.
    PubMed     Abstract available
    
    
    
79. MENG X, Kong X, Wu R, Yang Z, et al
    Total Body PET/CT: A Role in Drug Development?
    Semin Nucl Med. 2024 Oct 9:S0001-2998(24)00081.
    PubMed     Abstract available
    
    
    
80. STORMEZAND GN, de Meyer E, Koopmans KP, Brouwers AH, et al
    Update on the Role of [(18)F]FDOPA PET/CT.
    Semin Nucl Med. 2024 Oct 8:S0001-2998(24)00080.
    PubMed     Abstract available
    
    
    
81. AL-IBRAHEEM A, Abdlkadir AS, Shi H, Abdel-Razeq H, et al
    PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [(68)Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis.
    Semin Nucl Med. 2024 Oct 5:S0001-2998(24)00079.
    PubMed     Abstract available
    
    
    
82. ZHANG Q, Huang Z, Jin Y, Li W, et al
    Total-Body PET/CT: A Role of Artificial Intelligence?
    Semin Nucl Med. 2024 Oct 4:S0001-2998(24)00078.
    PubMed     Abstract available
    
    
    September 2024
83. MINGELS C, Chung KJ, Pantel AR, Rominger A, et al
    Total-Body PET/CT: Challenges and Opportunities.
    Semin Nucl Med. 2024 Sep 27:S0001-2998(24)00076.
    PubMed     Abstract available
    
    
    
84. NOSKOVICOVA L, Balogova S, Aveline C, Tassart M, et al
    (18)F-Fluorocholine-Positron Emission Tomography/Computerized Tomography (FCH PET/CT) Imaging for Detecting Abnormal Parathyroid Glands: Indication, Practice, Interpretation and Diagnostic Performance.
    Semin Nucl Med. 2024 Sep 20:S0001-2998(24)00075.
    PubMed     Abstract available
    
    
    
85. HICKS RJ, Ware RE, Callahan J
    Total-Body PET/CT: Pros and Cons.
    Semin Nucl Med. 2024 Sep 16:S0001-2998(24)00065.
    PubMed     Abstract available
    
    
    
86. NAYFEH M, Sayed A, Alwan M, Alfawara M, et al
    Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging.
    Semin Nucl Med. 2024;54:638-647.
    PubMed     Abstract available
    
    
    
87. CLERC OF, Vijayakumar S, Dorbala S
    Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects.
    Semin Nucl Med. 2024;54:717-732.
    PubMed     Abstract available
    
    
    
88. MILLER RJH, Slomka PJ
    Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends.
    Semin Nucl Med. 2024;54:648-657.
    PubMed     Abstract available
    
    
    August 2024
89. COURAULT P, Zimmer L, Lancelot S
    Toward Functional PET Imaging of the Spinal Cord.
    Semin Nucl Med. 2024 Aug 23:S0001-2998(24)00066.
    PubMed     Abstract available
    
    
    July 2024
90. WAHL RL, Kahl B
    The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?
    Semin Nucl Med. 2024 Jul 16:S0001-2998(24)00055.
    PubMed     Abstract available
    
    
    
91. KLEYNHANS J, Ebenhan T, Sathekge MM
    Expanding Role for Gallium-68 PET Imaging in Oncology.
    Semin Nucl Med. 2024 Jul 3:S0001-2998(24)00054.
    PubMed     Abstract available
    
    
    
92. SATHEKGE MM, Bouchelouche K
    Letter from the Editors.
    Semin Nucl Med. 2024;54:457-459.
    PubMed    
    
    
    June 2024
93. KATAL S, Patel P, Lee J, Taubman K, et al
    Total Body PET/CT: A Role in Musculoskeletal Diseases.
    Semin Nucl Med. 2024 Jun 28:S0001-2998(24)00049.
    PubMed     Abstract available
    
    
    
94. MAHAJAN S, Gavane S, Pandit-Taskar N
    Targeted Radiopharmaceutical Therapy for Bone Metastases.
    Semin Nucl Med. 2024 Jun 26:S0001-2998(24)00047.
    PubMed     Abstract available
    
    
    
95. DULLEA A, O'Sullivan L, O'Brien KK, Carrigan M, et al
    Diagnostic Accuracy of (18)F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews.
    Semin Nucl Med. 2024 Jun 20:S0001-2998(24)00044.
    PubMed     Abstract available
    
    
    
96. KAZIMIERCZYK R, Kaminski KA, Nekolla SG
    Cardiac PET/MRI: Recent Developments and Future Aspects.
    Semin Nucl Med. 2024 Jun 8:S0001-2998(24)00048.
    PubMed     Abstract available
    
    
    
97. DIMITRAKOPOULOU-STRAUSS A, Pan L, Sachpekidis C
    Total Body PET-CT Protocols in Oncology.
    Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00050.
    PubMed     Abstract available
    
    
    
98. CURRIE GM, Hawk KE, Rohren EM
    Generative Artificial Intelligence Biases, Limitations and Risks in Nuclear Medicine: An Argument for Appropriate Use Framework and Recommendations.
    Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00046.
    PubMed     Abstract available
    
    
    
99. SACHPEKIDIS C, Dimitrakopoulou-Strauss A
    Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer.
    Semin Nucl Med. 2024 Jun 1:S0001-2998(24)00045.
    PubMed     Abstract available
    
    
    May 2024
100. BOUCHELOUCHE K, Sathekge MM
     Letter from the Editors.
     Semin Nucl Med. 2024;54:311-312.
     PubMed    
     
     
     
101. HABERL C, Crean AM, Zelt JGE, Redpath CJ, et al
     Role of Nuclear Imaging in Cardiac Stereotactic Body Radiotherapy for Ablation of Ventricular Tachycardia.
     Semin Nucl Med. 2024;54:427-437.
     PubMed     Abstract available
     
     
     April 2024
102. PAEZ D, Giammarile F, Brink A, Garcia-Perez O, et al
     The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis.
     Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00032.
     PubMed     Abstract available
     
     
     
103. GUJA KE, Behr G, Bedmutha A, Kuhn M, et al
     Molecular Imaging with PET-CT and PET-MRI in Pediatric Musculoskeletal Diseases.
     Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00030.
     PubMed     Abstract available
     
     
     March 2024
104. VAN DER GEEST KSM, Gheysens O, Gormsen LC, Glaudemans AWJM, et al
     Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends.
     Semin Nucl Med. 2024 Mar 26:S0001-2998(24)00026.
     PubMed     Abstract available
     
     
     
105. HIGUCHI T, Serfling SE, Leistner DM, Speer T, et al
     FAPI-PET in Cardiovascular Disease.
     Semin Nucl Med. 2024 Mar 21:S0001-2998(24)00023.
     PubMed     Abstract available
     
     
     
106. GUJA KE, Ganjoo KN, Iagaru A
     Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.
     Semin Nucl Med. 2024 Mar 2:S0001-2998(24)00012.
     PubMed     Abstract available
     
     
     
107. EKMEKCIOGLU O, Albert NL, Heinrich K, Tolboom N, et al
     Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques.
     Semin Nucl Med. 2024;54:237-246.
     PubMed     Abstract available
     
     
     
108. EVANGELISTA L, Israel O
     Letter From the Guest Editors.
     Semin Nucl Med. 2024;54:181-182.
     PubMed    
     
     
     
109. FILIPPI L, Camedda R, Frantellizzi V, Urbano N, et al
     Functional Imaging in Musculoskeletal Disorders in Menopause.
     Semin Nucl Med. 2024;54:206-218.
     PubMed     Abstract available
     
     
     February 2024
110. KHALATBARI H, Shulkin BL, Parisi MT
     PET/CT and PET/MR in Soft Tissue Sarcoma: An Update.
     Semin Nucl Med. 2024 Feb 28:S0001-2998(24)00005.
     PubMed     Abstract available
     
     
     
111. ULANER GA, Vaz SC
     Women's Health Update: Growing Role of PET for Patients with Breast Cancer.
     Semin Nucl Med. 2024 Feb 16:S0001-2998(24)00006.
     PubMed     Abstract available
     
     
     
112. GIAMMARILE F, Knoll P, Paez D, Estrada Lobato E, et al
     Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine.
     Semin Nucl Med. 2024 Feb 15:S0001-2998(24)00001.
     PubMed     Abstract available
     
     
     
113. KHESSIB T, Jha P, Davidzon GA, Iagaru A, et al
     Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
     Semin Nucl Med. 2024 Feb 10:S0001-2998(24)00003.
     PubMed     Abstract available
     
     
     
114. EISAZADEH R, Shahbazi-Akbari M, Mirshahvalad SA, Pirich C, et al
     Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers Part II. [(18)F]F-FLT, [(18)F]F-FET, [(11)C]C-MET and Other Less-Commonly Used Radiotracers.
     Semin Nucl Med. 2024 Feb 7:S0001-2998(24)00002.
     PubMed     Abstract available
     
     
     January 2024
115. EVANGELISTA L, Guglielmo P, Pietrzak A, Lazar AM, et al
     The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health.
     Semin Nucl Med. 2024 Jan 12:S0001-2998(23)00105.
     PubMed     Abstract available
     
     
     
116. ZAMANI-SIAHKALI N, Mirshahvalad SA, Farbod A, Divband G, et al
     SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases.
     Semin Nucl Med. 2024 Jan 2:S0001-2998(23)00093.
     PubMed     Abstract available
     
     
     December 2023
117. BENTESTUEN M, Nalliah S, Stolberg MMK, Zacho HD, et al
     How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers.
     Semin Nucl Med. 2023 Dec 4:S0001-2998(23)00092.
     PubMed     Abstract available
     
     
     
118. TELLI T, Desaulniers M, Pyka T, Caobelli F, et al
     What Role Does PET/MRI Play in Musculoskeletal Disorders?
     Semin Nucl Med. 2023 Dec 2:S0001-2998(23)00091.
     PubMed     Abstract available
     
     
     November 2023
119. GHEYSENS O, de Ponfilly MP, Nocturne G, Seror R, et al
     [(18)F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects.
     Semin Nucl Med. 2023 Nov 28:S0001-2998(23)00083.
     PubMed     Abstract available
     
     
     
120. MOKOALA KMG, Ndlovu H, Lawal I, Sathekge MM, et al
     PET/CT and SPECT/CT for Infection in Joints and Bones: An Overview and Future Directions.
     Semin Nucl Med. 2023 Nov 27:S0001-2998(23)00087.
     PubMed     Abstract available
     
     
     
121. BRINK A, Israel O, Nadel H, Arevalo-Pardo M, et al
     Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce.
     Semin Nucl Med. 2023 Nov 18:S0001-2998(23)00086.
     PubMed     Abstract available
     
     
     
122. VOTER AF, Werner RA, Savas H, Gafita A, et al
     A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging.
     Semin Nucl Med. 2023 Nov 16:S0001-2998(23)00088.
     PubMed     Abstract available
     
     
     
123. BESSON FL, Nocturne G, Noel N, Gheysens O, et al
     PET/CT in Inflammatory and Auto-immune Disorders: Focus on Several Key Molecular Concepts, FDG, and Radiolabeled Probe Perspectives.
     Semin Nucl Med. 2023 Nov 14:S0001-2998(23)00084.
     PubMed     Abstract available
     
     
     
124. CARACCIOLO M, Castello A, Lopci E
     PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview.
     Semin Nucl Med. 2023 Nov 9:S0001-2998(23)00082.
     PubMed     Abstract available
     
     
     
125. GIUBBINI R, Paghera B, Dondi M, Estrada Lobato E, et al
     Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain.
     Semin Nucl Med. 2023;53:733-742.
     PubMed     Abstract available
     
     
     
126. LOW CS, Rao N
     Imaging of Gastrointestinal Bleeding: An Update.
     Semin Nucl Med. 2023;53:766-776.
     PubMed     Abstract available
     
     
     
127. SIRAJ QH
     Functional Imaging of Testicular Torsion.
     Semin Nucl Med. 2023;53:797-808.
     PubMed     Abstract available
     
     
     
128. LE ROUX PY, Le Pennec R, Salaun PY, Zuckier LS, et al
     Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices.
     Semin Nucl Med. 2023;53:743-751.
     PubMed     Abstract available
     
     
     
129. JABBARPOUR A, Ghassel S, Lang J, Leung E, et al
     The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review.
     Semin Nucl Med. 2023;53:752-765.
     PubMed     Abstract available
     
     
     
130. LINDENBERG L, Ahlman M, Lin F, Mena E, et al
     Advances in PET Imaging of the CXCR4 Receptor: [(68)Ga]Ga-PentixaFor.
     Semin Nucl Med. 2023 Nov 1:S0001-2998(23)00080.
     PubMed     Abstract available
     
     
     September 2023
131. MIRSHAHVALAD SA, Eisazadeh R, Shahbazi-Akbari M, Pirich C, et al
     Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers.
     Semin Nucl Med. 2023 Sep 24:S0001-2998(23)00073.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum